← FDA Drug Approvals (Drugs@FDA)

LACOSAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STERANCO HLTHCARE · Approved 2026-05-21

Drug application

FDA Application #

ANDA220366

Application type

Abbreviated New Drug Application (Generic)

Brand name

LACOSAMIDE

Generic name

Lacosamide

Active ingredients

LACOSAMIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

STERANCO HLTHCARE

First approval

2026-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown